JARID2 and leukemia: Notably, JARID2 is mutated and/or deleted in various types of leukaemia where PRC2 plays an onco-suppressor role.55,56 This suggests that JARID2-mediated PRC2 recruitment is essential for its tumour-suppressive functions.